GARDINER SANDRA A. 4

4 · Pulse Biosciences, Inc. · Filed Mar 24, 2021

Form 4

Period: 2020-12-09

CFO & EVP Admin. and Finance

Transactions

Award
Stock Option (right to buy)
2021-03-22+18,000→ 18,000 total
Exercise: $24.03From: 2022-03-01Exp: 2031-03-22→ Common Stock (18,000 underlying)
Award
Stock Option (right to buy)
2021-02-23+8,750→ 8,750 total
Exercise: $10.66Exp: 2030-05-18→ Common Stock (8,750 underlying)
Award
Stock Option (right to buy)
2020-12-09+25,961→ 25,961 total
Exercise: $13.94Exp: 2029-11-18→ Common Stock (25,961 underlying)

Footnotes (3)

[F1]Represents the acquisition of vested options upon the determination of the Compensation Committee of the Board of Directors of the Issuer that certain performance conditions were met with respect to performance-based stock options granted to the Reporting Person on November 18, 2019.
[F2]Represents the acquisition of vested options upon the determination of the Compensation Committee of the Board of Directors of the Issuer that certain performance conditions were met in 2020 with respect to performance-based stock options granted to the Reporting Person on May 18, 2020.
[F3]The shares subject to the option will vest in equal annual installments over the following four years on the anniversary of March 1, 2021, subject to the Reporting Person's continued service through each vesting date.

Documents

1 file